(Reuters) - Merck & Co Inc said on Sunday it has submitted an application to the U.S. Food and Drug Administration for its drug Keytruda as a treatment for advanced non-small cell lung cancer, the most common form of the disease. Keytruda, also ... Reuters, 3 hours ago
Merck Cancer Drug Shines Against Skin, Lung Cancer - TeleTrader.com, 36 minutes ago
Merck cancer drug is first approved under UK early access scheme - Reuters, 1 month ago
Merck & Co.'s new cancer drug Keytruda improved the survival odds of patients with the skin cancer melanoma compared with Bristol-Myers Squibb Co.'s Yervoy, in the first head-to-head study of a new wave of drugs that harness the body's immune system ...Austin American Statesman, 2 hours ago Merck's Keytruda Shows Improved Survival Odds for Melanoma Patients 4 Traders, 2 hours ago Merck''s Keytruda Shows Improved Survival Odds for Melanoma Patients Nasdaq, 2 hours ago
(Reuters) - Merck & Co Inc's Keytruda, approved for treating melanoma, was shown in a trial to shrink tumors in nearly half of advanced lung cancer patients with high levels of a protein used by tumors to evade the body's own disease-fighting cells.Reuters, 3 hours ago
Merck has received two new breakthrough therapy designations from the FDA for grazoprevir/elbasvir, an investigational single tablet regimen, for the treatment of patients with chronic HCV genotype 4, or GT4, infection, and for the treatment of ...Individual.com, 1 day ago FDA gives Merck Breakthrough Therapy designation to treat chronic hepatitis C virus in dialysis patients NephrologyNews.com, 1 week ago Merck's HCV Combo Drug Gets Two Breakthrough Status - Analyst Blog Zacks.com, 1 week ago FDA Grants Breakthrough Designations to Merck's Hepatitis C Candidate Pharmacy Times, 1 week ago
Merck & Co Inc. (http://www.marketintelligencecenter.com/symbol/MRK"MRK) presents a trading opportunity that offers a 2.92% return in just 63 days. A covered call on Merck at the $57.50 level expiring on Jun. '15 offers an assigned return rate of ...Individual.com, 1 day ago
Fitch Ratings has downgraded pharmaceutical company Merck & Co's rating to A from A+, though it also revised the outlook to stable from negative, citing improving margins. Shares of Merck were recently down less than 1% in midday trading. ...Morningstar.com, 5 days ago Fitch Downgrades Merck's L-T IDR to 'A'; Outlook Revised to Stable Reuters UK, 5 days ago Careful, European drugmakers. Fitch says M&A may be a bit too heated FiercePharma, 2 days ago
(FreshBrewedMedia) The patented options-trade picking algorithms used by MarketIntelligenceCenter.com found a trading opportunity with Merck & Co Inc. ( MRK ) that should provideIndividual.com, 4 days ago Merck (MRK) Trading Near $58.44 Resistance Level Individual.com, 1 week ago Merck (MRK) Trading Near $56.80 Support Level Individual.com, 1 week ago
CNBC Excerpts: CNBC Exclusive: Merck Chairman & CEO Ken Frazier Speaks with CNBC's Meg Tirrell Today on "Power Lunch"
WHEN: Today, Thursday, April 16th WHERE: CNBC's "" Following are excerpts from the unofficial transcript of a CNBC EXCLUSIVE interview with Merck Chairman & CEO Ken Frazier on CNBC's "Power Lunch" (M-F, 1PM-3PM ET) today.CNBC, 2 days ago
MERCK KGAA : Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® crizotinib
By a News Reporter-Staff News Editor at Pharma Business Week -- Merck KGaA, Darmstadt , Germany , and Pfizer Inc. , New York , US, announced the finalization of the co-promotion agreement allowing the companies to co-promote Pfizer's anaplastic ...4 Traders, 3 days ago Pfizer, Merck KGaA sign pact to co-promote ALK inhibitor Xalkori PharmaBiz, 1 week ago Merck, Pfizer to co-market potential cancer drug Bio Spectrum Asia, 1 week ago Merck and Pfizer to co-promote cancer drug Pharmafocus, 1 week ago
After FridayaEUR(TM)s trading in Merck & Co Inc. (http://www.marketintelligencecenter.com/symbol/MRK"MRK) MarketIntelligenceCenter.com's patented algorithms uncovered a trade that offers a 2.04% return or 7.84% on an annualized basis (for comparison ...Individual.com, 5 days ago Potential Merck (MRK) Trade Has 3.51% Downside Protection Individual.com, 3 days ago
on your WebpageAdd Widget >Get your members hooked!